The Emerging Role of Herbal Medicine in Health Care in Europe

  • PDF / 245,968 Bytes
  • 3 Pages / 504 x 719.759 pts Page_size
  • 108 Downloads / 166 Views

DOWNLOAD

REPORT


Drug Infomarion Journal. Vol. 32. pp. 151-153, 1998 Printed in the USA. All rights reserved.

THE EMERGING ROLE OF HERBAL MEDICINE IN HEALTH CARE IN EUROPE JOERG GRUENWALD, PHD President, PhytoPharm Consulting, Berlin, Germany

Europe has a very long tradition in phytomedicines, dating back to the first century A. D. Today, almost 40% of all drugs listed in the German Physicians Desk Reference are derived from plant material. Fijty percent of the world sales of herbal remedies occur in Europe with a retail sales volume of over $6 billion. In several countries such as Germany and France health insurance companies cover the reimbursement of several herbal drugs. Within Europe, Germany is the leading country for herbal drugs with annual sales of $2.5 billion and per capita spending of $37 on phytomedicines, followed by France, Italy, the United Kingdom, Spain, the Netherlands, and Belgium. At the moment, the licensing of herbal drugs differs in Europe from country to country, Germany, for example, established a monograph system and France a list of plants and indications. In other Member States phytomedicines are still nonregistered dietary supplements such as in the Netherlands and partially in the United Kingdom. The situation will change in the near future since the European laws declare all herbal preparations are drugs which have to be licensed on the basis of their quality, safety, and efficacy. The leading plants prescribed as mono-preparations in Germany are Ginkgo biloba, Horse-chestnut, Hawthorn. and St. John’s Wort with very high growth rates that are stronger than most of their chemical competitors. The phytomedicines industry is in the process of concentration. Smaller phytomedicines companies are being bought up by multinational pharmaceutical companies. In other cases, specialized small companies produce products for multinational companies. Europe has the most developed market in the world in the area of phytomedicines with the best established criteria for licensing and quality control. It can be regarded as a model for other international development. Key Words: Phytomedicines; Herbal medicine; Botanicals; Ginkgo biloba; St. John’s Wort; Garlic

use of plants as herbal remedies. In the first century A.D. the Greek physician DioscoriHERBAL a long tradition dis prepared the first European report on the in Europe. After China, Central Europe has properties and use of medicinal plants. In capturedthe best documentation On the later periods, special treatment methods such as homeopathy appeared. In more recent times, traditional medicine in Europe has Presented at the 32nd DIA Annual Meeting “The Chal- been developed and diversified even further. lenge of Worldwide Pharmaceutical Development in an In many countries such as Germany, France, of RedatOV Change: Accelerated ApproVal With or Italy treatment with phytotherapeutics has Quality and Contained Cost,” June 9-13, 1996, San become well established and is regulated by Diego, California. Repint address: m, jWrgmenw&j, phytopharm the federal authorities.